Tenders Are Invited For Medicines With The Active Ingredient Ebastine (Atc: R06ax22) in Germany

Work Detail

Medicines With The Active Ingredient Ebastine (Atc: R06ax22). The Subject Of This Publication Is The Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Ebastine (Atc: R06ax22) As Part Of A So-Called Openhouse Model. Subject To Uniform Contractual Conditions And A Uniform Access Procedure, All Suitable And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Are Offered The Opportunity To Conclude Or Join A Discount Agreement In Accordance With Section 130 A Paragraph 8 Sgb V For The Active Ingredients Mentioned In Section B. Interested Pharmaceutical Companies Can Request The Participation Documents And The Respective Contract From The Contact Address Given Under I.1). The Prerequisite For Concluding A Contract Is That The Interested Pharmaceutical Company Submits The Requested Participation Documents, Completely Completed And Signed.

Contact Information